Evidence map›Paper›PMID 23392687›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2013

A target cell-specific role for presynaptic Fmr1 in regulating glutamate release onto neocortical fast-spiking inhibitory neurons.

Ankur B Patel, Seth A Hays, Ingrid Bureau, Kimberly M Huber, Jay R Gibson

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Article
  3. Anterior piriform cortex dysfunction underlies autism spectrum disorders-related olfactory deficits in Fmr1 conditional deletion mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  4. GABAergic Progenitor Cell Graft Rescues Cognitive Deficits in Fragile X Syndrome Mice.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Hyperexcitability and Homeostasis in Fragile X Syndrome.Frontiers in molecular neuroscience · 2021
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Ankur B PatelUniversity of Texas Southwestern Medical Center, Department of Neuroscience, Dallas, Texas 75390-9111, USA.
Seth A Hays
Ingrid Bureau
Kimberly M Huber
Jay R Gibson
The University of Texas Southwestern Medical Center · USInstitut de Microbiologie de la Méditerranée · FR

Funding

DIVISION OF CELL &MOLECULAR BIOLOGY TRAINING PROGRAMT32GM008203 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI COBB, MELANIE H. · 1987 to 2018
$7.0M
Study of Fragile X Mental Retardation Protein in Synaptic Function and PlasticityR01HD052731 · NICHD · UT SOUTHWESTERN MEDICAL CENTER · PI GIBSON, JAY ROBERT, HUBER, KIMBERLY M. · 2008 to 2022
$6.0M
Cortical circuit changes and mechanisms in a mouse model of Fragile X SyndromeR01HD056370 · NICHD · UT SOUTHWESTERN MEDICAL CENTER · PI GIBSON, JAY ROBERT · 2009 to 2012
$1.2M
The Cellular Biophysics of the Neuron Training ProgramT32NS069562 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI KAVALALI, EGE T · 2010 to 2014
$568k
NICHD NIH HHS HD052731NICHD NIH HHS HD056370NICHD NIH HHS R01 HD052731NICHD NIH HHS R01 HD056370NIGMS NIH HHS GM008203NIGMS NIH HHS T32 GM008203NINDS NIH HHS 1T32NS069562NINDS NIH HHS T32 NS069562
6 · The paper itself

Abstract

In the mouse model of Fragile X syndrome, the Fmr1 knock-out, local excitation of layer 4 fast-spiking (FS) inhibitory neurons is robustly decreased by 50%, but the mechanisms mediating this change are unknown. Here, we performed recordings in acutely prepared slices obtained from Fmr1 "mosaic" mice, where Fmr1 is deleted in about half of all neurons, and we found that loss of presynaptic, but not postsynaptic, Fmr1 fully recapitulates the deficit. The change in connection strength is primarily due to a decrease in release probability indicating that FMRP normally positively regulates these processes. This change in presynaptic neurotransmitter release is observed both in the mosaic mice and in the constitutive Fmr1 knock-out mice. Manipulations in release probability enabled both the mimic and rescue of the impaired function in this synaptic pathway. Loss of presynaptic Fmr1 has no effect on excitatory synapses onto excitatory neurons, indicating a target cell-specific function for presynaptic FMRP. Finally, we demonstrate that the excitation decrement onto FS neurons also exists in layer 5 of the Fmr1 knock-out, suggesting a widespread role for presynaptic Fmr1 in the excitation of inhibitory neurons. In summary, we identify a novel function for presynaptic FMRP in promoting presynaptic neurotransmitter release, and we show that loss of this function accounts for impaired excitation of neocortical FS inhibitory neurons. These changes may contribute to the cognitive dysfunction and circuit hyperexcitability associated with Fragile X syndrome, including patients with complete deletion of FMRP and those with mosaic expression of FMRP.

Indexed as

Action PotentialsAnimalsDizocilpine MaleateExcitatory Postsynaptic PotentialsFemaleFragile X Messenger Ribonucleoprotein 1Glutamic AcidInhibitory Postsynaptic PotentialsMaleMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicNeocortexNeural InhibitionNeuronsDizocilpine MaleateFmr1 protein, mouseFragile X Messenger Ribonucleoprotein 1Glutamic Acid

Identifiers

PMID23392687
PMCPMC3711607
OpenAlexW1963904371

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.